What Is Hyperthermia?

Hyperthermia is a therapeutic technique in which tissue temperature is intentionally elevated, typically to between 40°C and 45°C, to exploit the biological sensitivity of diseased cells to heat. In oncology, its primary application, cancer cells within poorly vascularized tumors are less able to dissipate heat than surrounding healthy tissue, making selective thermal damage feasible. The approach has been studied since the mid-twentieth century, when clinical observations of tumor regression in patients with high fevers prompted systematic investigation of heat as a treatment modality.

Hyperthermia draws on biomedical engineering, oncology, biophysics, and electromagnetics. Heating can be achieved by several physical mechanisms: external electromagnetic applicators using radiofrequency or microwave energy, ultrasonic transducers that deposit acoustic energy, magnetic nanoparticles that generate heat when exposed to an alternating magnetic field, and interstitial or intracavitary probes placed directly within or adjacent to a tumor. Each modality involves distinct physics, device engineering, and treatment planning requirements.

Electromagnetic Heating

Electromagnetic heating is the most widely studied mechanism in clinical hyperthermia. Radiofrequency applicators in the 13.56 MHz and 27.12 MHz bands penetrate deeply enough for locoregional heating of abdominal and pelvic tumors, while microwave phased arrays operating at 433 MHz to 915 MHz can steer a focal hot spot into deep-seated targets by controlling the amplitude and phase of each antenna element. As detailed in IEEE Xplore research on hyperthermia by electromagnetic fields in oncology, the spatial distribution of power deposition depends on tissue dielectric properties, applicator geometry, and the degree of coherent focusing achieved by the array. Skin cooling with water boluses is required to prevent superficial burns while the deeper field concentrates energy at the tumor. Finite element and method-of-moments electromagnetic solvers are routinely used during treatment planning to predict specific absorption rate (SAR) distributions in patient-specific anatomical models.

Thermal Dosimetry and Treatment Planning

Effective hyperthermia requires accurate knowledge of the temperature field throughout the target volume. Thermometry methods include invasive thermistor or thermocouple probes inserted along catheters within the tumor and non-invasive approaches such as MRI-based thermometry, which tracks changes in proton resonance frequency to map temperature in three dimensions. Thermal dose is quantified by the cumulative equivalent minutes at 43°C (CEM43), a time-temperature integral that normalizes exposures at different temperatures to a common reference. Research published in a review of biomedical engineering contributions to hyperthermia established that achieving a minimum CEM43 of 10 to 30 minutes throughout the clinical target volume correlates with improved local tumor control. Treatment planning software integrates electromagnetic field simulation with bioheat transfer models to predict temperature distributions and optimize applicator settings before and during a session.

Sensitization of Radiotherapy and Chemotherapy

Hyperthermia is rarely administered as a standalone treatment. Its principal clinical value lies in its ability to enhance the cytotoxic effects of radiation and certain chemotherapeutic drugs. At the cellular level, temperatures above 42°C inhibit the repair of radiation-induced DNA double-strand breaks, causing heat and radiation damage to act synergistically. Hyperthermia also improves drug delivery by increasing tumor blood flow and vascular permeability, which raises intratumoral drug concentration. The magnetic induction review in IEEE Transactions on Biomedical Engineering outlines how magnetic nanoparticle hyperthermia, in which iron oxide particles injected into a tumor are excited by an external alternating field, offers a route to spatially confined heating that can be combined with both radiation and systemic chemotherapy.

Applications

Hyperthermia has applications in a wide range of disciplines, including:

• Adjuvant cancer treatment alongside radiotherapy and chemotherapy
• Deep regional heating for pelvic, abdominal, and thoracic tumors
• Superficial tumor therapy for chest wall recurrences
• Nanoparticle-mediated local tumor ablation
• Physical therapy for musculoskeletal conditions and pain management